The coordinated alteration of freely circulating and EV-associated miRNAs highlight the potential contribution of miRNA-mediated regulation to premature HPG axis activation and provides a framework for further investigation of the molecular mechanisms underlying pubertal disorders.
Abstract
Background Central precocious puberty (CPP) results from premature activation of the hypothalamic–pituitary–gonadal (HPG) axis. While hormonal mechanisms underlying pubertal initiation are well established, the molecular regulatory processes accompanying altered pubertal timing remain incompletely understood. Circulating microRNAs (miRNAs), detectable either freely or within extracellular vesicles (EVs), represent a molecular layer of post-transcriptional regulation associated with pubertal development. Methods Serum samples from female patients diagnosed with CPP and age-matched healthy female controls were analyzed by small RNA sequencing to identify differentially expressed miRNAs. Selected miRNAs were validated by quantitative real-time PCR (RT–qPCR) in an expanded cohort using serum RNA and RNA isolated from serum-derived EVs. Functional enrichment analysis was conducted using experimentally validated miRNA target genes. Results Small RNA sequencing identified ten miRNAs with significantly altered expression levels in CPP (adjusted p-value < 0.05, |log2FC| > 0.5). Pathway enrichment analysis highlighted biological processes related to neurodevelopment, growth regulation and cellular maturation. RT–qPCR validation confirmed reduced serum expression of miR-125a-5p, miR-125b-5p and miR-99b-5p in CPP patients. All selected miRNAs were detectable in serum-derived EVs. Notably, miR-148a-3p exhibited a statistically significant increase specifically within the EV-associated fraction of CPP samples. Conclusions This study provides a comprehensive analysis of the circulating miRNA profile in female patients with CPP. The coordinated alteration of freely circulating and EV-associated miRNAs highlight the potential contribution of miRNA-mediated regulation to premature HPG axis activation and provides a framework for further investigation of the molecular mechanisms underlying pubertal disorders.
Pilot study results suggest potential miRNAs and their target pathway links with PCOS that need validation in larger cohorts for diagnostic or therapeutic applications need validation in larger cohorts for diagnostic or therapeutic applications.
A potential role for dysregulation of the exosomal lncRNA-miRNA-mRNA regulatory axis, particularly involving IL-6 and TGF-β1 mRNA expression, in the inflammatory processes associated with PCOS is suggested.
Kamand Adhami, Mohammad Karimian, Zahra Karimian· Scientific Reports· 0 citations
This work aimed to identify a specific miRNA signature to better characterize FTD pathology and revealed that miR-365a-3p and miR-212 were significantly down-regulated in FTD.
Evelyne Minucchi, F. Dragoni, R. Di Gerlando et al.· Genes· 0 citations
Potential biological mechanisms by which placental microRNA dysfunction might contribute to spontaneous preterm birth are highlighted and putative sPTB biomarkers that may be detectable in maternal circulation are highlighted.
Mariana Parenti, Elizabeth M. Kennedy, Evan J. Firsick et al.· bioRxiv· 0 citations
Stigmasterol exhibits significant therapeutic effects against CPP by concurrently targeting the IGF-1/PI3K/Akt/mTOR and Kisspeptin/GnRH signaling pathways.
Lin Dong, Yan Xing, Xiaoning Li et al.· Biochimica et Biophysica Act...· 0 citations
Analysis of total serum miRNAs provides a more sensitive and robust approach for identifying individuals with prediabetes, which correlates with the exosomal fraction, and can infer that miR-195-5p and miR-6838-5p are novel, high-performance circulatory biomarkers detecting T2DM.
A. Mendonça, J. Kumar, Sujatha Sundaresan· Diabetes Research and Clinic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.